Which of the following is the chemoprophylaxis of choice in a person who is on a journey to endemic malarial region?
**Core Concept:** Chemoprophylaxis is the use of medications to prevent or reduce the risk of a specific disease or condition. In this case, we are discussing chemoprophylaxis for malaria, a parasitic infection caused by Plasmodium species. Malaria is transmitted to humans through the bite of infected Anopheles mosquitoes. Chemoprophylaxis is used to prevent the infection from occurring or to reduce the severity and duration of the disease if an infection occurs.
**Why the Correct Answer is Right:** The correct answer, Doxycycline, is a tetracycline antibiotic that is effective against several pathogens, including Plasmodium species. Doxycycline is commonly prescribed for malaria prophylaxis due to its excellent pharmacokinetic properties and safety profile. When taken daily, it can reduce the risk of Plasmodium infection and decrease the severity and duration of malaria symptoms if the infection occurs.
**Why Each Wrong Option is Incorrect:**
A. Chloroquine (CQ) is a chloroquine-based antimalarial medication. However, its efficacy against Plasmodium species has declined due to the emergence of drug-resistant strains. As a result, it is not the first choice for chemoprophylaxis in endemic regions.
B. Mefloquine (Lariam) is a prophylactic agent for malaria. However, it has been associated with psychiatric side effects, particularly in asymptomatic patients. This significantly limits its use for long-term chemoprophylaxis.
C. Primaquine is a 8-aminoquinoline drug used for the radical cure of Plasmodium infection. It is not suitable for chemoprophylaxis, as it requires a dose tapering regimen and is contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, which is prevalent in some regions.
**Clinical Pearl:** Malaria chemoprophylaxis should be tailored to the specific Plasmodium species prevalent in the region and the patient's individual factors, such as G6PD deficiency and potential side effects. Consulting a healthcare professional is crucial for selecting the appropriate chemoprophylactic agent and ensuring patient safety.